SCHEMBL5556540

SCHEMBL5556540

CCC(=O)Nc1ccc2c(c1)CCN(C(=O)O)CC2C(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.44
KDM4E B2RXH2 1/20 0.39
POLB P06746 3/20 0.39
ATAD2 Q6PL18 2/20 0.39
CHEK1 O14757 1/20 0.39
AURKA O14965 1/20 0.39
DAPK3 O43293 1/20 0.39
JAK2 O60674 1/20 0.39
PRKD3 O94806 1/20 0.39
PAK4 O96013 1/20 0.39
ABL1 P00519 1/20 0.39
NTRK1 P04629 1/20 0.39
LCK P06239 1/20 0.39
FYN P06241 1/20 0.39
CSF1R P07333 1/20 0.39
RET P07949 1/20 0.39
IGF1R P08069 1/20 0.39
MET P08581 1/20 0.39
PDGFRB P09619 1/20 0.39
PIM1 P11309 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5244515 0.89 ALOX5 (0.35) RAB9AKDM4ETMPRSS2HTR1A
SCHEMBL2312465 0.88 HTR1A (0.43) RAB9ASMN1; SMN2ALDH1A1HTR1AMEN1
SCHEMBL5242804 0.86 NPC1 (0.35) RAB9AKDM4ETMPRSS2HTR1A
SCHEMBL4770219 0.82 NPC1 (0.47) RAB9AKDM4ESMN1; SMN2ALDH1A1MAPT
SCHEMBL4767049 0.81 PKM (0.47) RAB9AKDM4EPOLBROCK1SMN1; SMN2
SCHEMBL5556546 0.81 RAB9A (0.43) RAB9AKDM4EPOLBCHEK1AURKA
SCHEMBL4637682 0.80 NR1H2 (0.46) ATAD2HTR1A
SCHEMBL2124644 0.79 ESR2 (0.45)
SCHEMBL5170173 0.78 ALDH1A1 (0.34) KDM4ENAMPTALDH1A1MEN1KMT2A
SCHEMBL19638276 0.78 CAMK2A (0.41) CAMK2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751163-A2 COMPOUNDS HAVING AFFINITY FOR DOPAMINE D3 RECEPTOR AND USES THEREOF GLAXO GROUP LIMITED (GB) 2007-02-14 EP disclosed
WO-2005118549-A2 COMPOUNDS HAVING AFFINITY FOR DOPAMINE D3 RECEPTOR AND USES THEREOF GLAXO GROUP LIMITED (GB) 2005-12-15 WO disclosed